General Information of the Compound
Compound ID
CP0041197
Compound Name
(S)-2-(4,6-Dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid
    Show/Hide
Synonyms
Darusentan
Endothelin antagonist, BASF
HMR-4005
LU-127043
LU-135252
    Show/Hide
Structure
Formula
C22H22N2O6
Molecular Weight
410.426
Canonical SMILES
COc1cc(OC)nc(O[C@H](C(O)=O)C(OC)(c2ccccc2)c2ccccc2)n1
    Show/Hide
InChI
InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
    Show/Hide
InChIKey
FEJVSJIALLTFRP-LJQANCHMSA-N
CAS
171714-84-4
177036-80-5
Physicochemical Property
logP
2.916
Rotatable Bonds
9
Heavy Atom Count
30
Polar Areas
100
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 177236
SID: 12015030
ChEMBL ID
CHEMBL23261
DrugBank ID
DB04883
Clinical Information about the Compound
Drug 1 ( Darusentan )
Drug Name Darusentan
Company Gilead Sciences; Knoll GmbH
Indication
Hypotension
Phase 3
Target(s)
Endothelin A receptor (EDNRA)
Antagonist